X0206 3 2021-07-09 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001751478 Johnson Brady 6310 NANCY RIDGE DRIVE SAN DIEGO CA 92121 0 1 0 0 Vice President, Finance Common Stock 26369 D Stock Option (right to buy) 2.45 2026-12-17 Common Stock 12111 D Stock Option (right to buy) 2.45 2026-12-17 Common Stock 20012 D Stock Option (right to buy) 1.98 2030-03-18 Common Stock 6700 D Stock Option (right to buy) 2.55 2031-03-16 Common Stock 12150 D Restricted Stock Unit Common Stock 524 D One-third (1/3) of the shares subject to the option vested on December 18, 2020 and the remainder vests and becomes exercisable in a series of twenty-four (24) successive equal monthly installments thereafter until fully vested on December 18, 2022. Shares are fully vested The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19, 2020. The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021. The shares shall vest upon the achievement of various clinical and corporate milestones. Restricted stock units convert into common stock on a one-for-one basis. /s/ Brady Johnson 2021-07-19